
Tenofovir + Emtricitabine
300/200mg
Tenofovir and emtricitabine are combined in a tablet for HIV infection and pre-exposure prophylaxis. It is supplied in a single strength; pack sizes vary. Each option lists its price per tablet.
HIV is a virus that attacks CD4 immune cells. Without treatment, it weakens the body’s defences over time. Modern antiretroviral therapy (ART) can suppress the virus to undetectable levels, allowing people on effective treatment to stay well and live with HIV as a manageable chronic condition.

300/200mg
Tenofovir and emtricitabine are combined in a tablet for HIV infection and pre-exposure prophylaxis. It is supplied in a single strength; pack sizes vary. Each option lists its price per tablet.
Early infection often causes a short flu-like illness with fever, swollen glands and sore throat, which resolves on its own. After that, the infection enters a prolonged phase with no symptoms, and CD4 counts decline slowly during this time.
ART uses medicines from several drug classes to keep the virus below detectable levels. Treatment is lifelong; pausing allows the virus to resurge. Examples include Tenofovir + Emtricitabine tablets 300/200mg, combining tenofovir and emtricitabine, and Kaletra tablets 200/50mg, combining lopinavir and ritonavir. The tenofovir/emtricitabine combination is also used for pre-exposure prophylaxis. Orders are prepared by licensed pharmacy partners in India and shipped to Malaysia in discreet packaging.
Same-day medical attention is needed for confusion, a stiff neck, a sudden severe headache, breathing difficulty, or rapid weight loss that has no clear cause in a person with HIV. Such signs may point to an opportunistic infection that requires urgent treatment.
Last updated